Polymer drugs of paclitaxel binding national patent, the Chinese Fine Chemicals net

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) January 11, 2011 -- By the researcher of Chinese Academy of Sciences, Changchun JING Xia-bin,CAS 51889-44-2 , who invented the.

Is recognized as the first-line paclitaxel chemotherapy drugs, but because the source is limited, expensive, have severe allergic reactions, many patients can not or should not be used.

In the past few years, Chinese Academy of Sciences, Changchun Institute of Applied Chemistry JING Xia-bin Task Force developed with independent property rights in order to lactic acid polymer amphiphilic block copolymers as the carrier of paclitaxel polymer binding drugs. Drug taxol from the fundamental solution to the problem of allergic reactions,CAS 603-33-8 , is expected to replace the current clinical use of paclitaxel formulations. As a result of chemical drug molecules covalently linked to the carrier polymer, and the formulation has been successful in avoiding physical coated micelle other early burst release phenomenon. Source: http://www.mhcfm.com

Fine Chemicals